OXYCODONE AND ACETAMINOPHEN

OXYCODONE AND ACETAMINOPHEN was reported 23376 times

OXYCODONE AND ACETAMINOPHEN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 39 0.1703
1 VISION ABNORMAL NEONATAL 71 0.1699
2 DEPENDENCE 8744 0.1593
3 SWOLLEN JOINT COUNT 30 0.1200
4 NEONATAL HYPOACUSIS 26 0.1088
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 185 0.0924
6 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 527 0.0811
7 LUPUS VULGARIS 101 0.0802
8 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 44 0.0784
9 MUSCLE INJURY 624 0.0752
10 X-RAY ABNORMAL 133 0.0743
11 DUODENAL ULCER PERFORATION 544 0.0731
12 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 524 0.0731
13 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 48 0.0719
14 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 148 0.0714
15 C-REACTIVE PROTEIN 63 0.0680
16 LEARNING DISABILITY 357 0.0670
17 SWOLLEN JOINT COUNT INCREASED 202 0.0633
18 DISLOCATION OF VERTEBRA 141 0.0618
19 FOLLICULITIS 638 0.0608
20 PORPHYRIA ACUTE 78 0.0544
21 HELICOBACTER INFECTION 558 0.0542
22 FACET JOINT SYNDROME 169 0.0519
23 ILL-DEFINED DISORDER 3107 0.0511
24 RHEUMATIC FEVER 219 0.0491
25 PEMPHIGUS 563 0.0450
26 RETINITIS 77 0.0445
27 DEVELOPMENTAL DELAY 391 0.0433
28 HAND DEFORMITY 565 0.0430
29 VASCULAR GRAFT OCCLUSION 16 0.0417
30 DRUG WITHDRAWAL SYNDROME NEONATAL 616 0.0416
31 RHEUMATOID FACTOR POSITIVE 224 0.0387
32 PERIPHERAL VENOUS DISEASE 154 0.0377
33 PRODUCT USED FOR UNKNOWN INDICATION 47 0.0373
34 PRESBYACUSIS 11 0.0357
35 PERICARDITIS 558 0.0332
36 IRRITABLE BOWEL SYNDROME 654 0.0305
37 SYNOVITIS 538 0.0298
38 SUBSTANCE USE DISORDER 94 0.0295
39 WITHDRAWAL SYNDROME 1149 0.0273
40 C-REACTIVE PROTEIN ABNORMAL 164 0.0255
41 GLOSSODYNIA 569 0.0254
42 BONE EROSION 89 0.0251
43 TENOSYNOVITIS STENOSANS 12 0.0215
44 POST-TRAUMATIC STRESS DISORDER 143 0.0213
45 MATERNAL EXPOSURE TIMING UNSPECIFIED 75 0.0199
46 AUTOIMMUNE DISORDER 194 0.0199
47 IMPAIRED HEALING 651 0.0198
48 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 21 0.0198
49 PERSONAL RELATIONSHIP ISSUE 13 0.0194
50 OVERDOSE 4118 0.0191
51 WOUND 533 0.0190
52 SERONEGATIVE ARTHRITIS 21 0.0183
53 SEDATION 475 0.0181
54 BURSITIS 218 0.0179
55 TEMPERATURE REGULATION DISORDER 40 0.0179
56 HYPERPARATHYROIDISM SECONDARY 44 0.0175
57 PLEURAL THICKENING 12 0.0175
58 LIP DRY 155 0.0170
59 WOUND INFECTION 179 0.0163
60 JOINT RANGE OF MOTION DECREASED 218 0.0162
61 SYSTEMIC LUPUS ERYTHEMATOSUS 573 0.0161
62 BONE DEMINERALISATION 17 0.0161
63 BREAST CANCER STAGE III 104 0.0160
64 DRUG TOLERANCE DECREASED 44 0.0157
65 GRIP STRENGTH DECREASED 134 0.0152
66 WALKING AID USER 100 0.0152
67 HYPERCHOLESTEROLAEMIA 145 0.0150
68 LOWER RESPIRATORY TRACT INFECTION 673 0.0148
69 TOOTH EROSION 18 0.0147
70 NEPHROGENIC ANAEMIA 65 0.0140
71 REBOUND ACID HYPERSECRETION 42 0.0139
72 CONTRAINDICATED PRODUCT ADMINISTERED 410 0.0135
73 PUSTULAR PSORIASIS 45 0.0131
74 EXOSTOSIS 119 0.0130
75 NIGHTMARE 448 0.0129
76 LEARNING DISORDER 31 0.0128
77 PLEURAL FIBROSIS 13 0.0128
78 CARDIAC DEATH 15 0.0124
79 BLOOD MAGNESIUM INCREASED 11 0.0122
80 LOWER LIMB FRACTURE 234 0.0122
81 ALLERGY TO CHEMICALS 15 0.0120
82 DISABILITY 237 0.0120
83 BONE CYST 11 0.0117
84 BLISTER 656 0.0117
85 FIBROMYALGIA 281 0.0115
86 SCIATICA 184 0.0115
87 PRE-EXISTING CONDITION IMPROVED 72 0.0115
88 THERAPEUTIC PRODUCT EFFECT DECREASED 503 0.0112
89 HIP ARTHROPLASTY 170 0.0111
90 STOMATITIS 667 0.0110
91 OBESITY 175 0.0110
92 SPEECH DISORDER DEVELOPMENTAL 31 0.0108
93 ARTHROPATHY 600 0.0108
94 LUPUS-LIKE SYNDROME 92 0.0101
95 PRESCRIBED OVERDOSE 192 0.0099
96 END STAGE RENAL DISEASE 180 0.0099
97 INFUSION RELATED REACTION 650 0.0098
98 ATTENTION DEFICIT HYPERACTIVITY DISORDER 41 0.0097
99 NEPHROLITHIASIS 441 0.0096
100 GASTRIC DILATATION 16 0.0096
101 DISCOMFORT 585 0.0096
102 OSTEOSCLEROSIS 15 0.0095
103 RASH VESICULAR 46 0.0095
104 DRUG TOLERANCE 48 0.0095
105 LIVER INJURY 229 0.0093
106 INFUSION SITE DISCHARGE 16 0.0091
107 HEPATIC ENZYME INCREASED 621 0.0091
108 DRUG SCREEN NEGATIVE 16 0.0091
109 KNEE ARTHROPLASTY 191 0.0091
110 FOOT DEFORMITY 99 0.0089
111 ECONOMIC PROBLEM 131 0.0086
112 NIGHT SWEATS 278 0.0086
113 TYPE 2 DIABETES MELLITUS 287 0.0085
114 GASTROINTESTINAL DISORDER 755 0.0084
115 JOINT DISLOCATION 87 0.0082
116 FOETAL EXPOSURE DURING PREGNANCY 653 0.0080
117 SWELLING 718 0.0077
118 SINUSITIS 786 0.0077
119 DRUG DIVERSION 47 0.0076
120 FOETAL DEATH 39 0.0075
121 PULMONARY FIBROSIS 144 0.0075
122 ROAD TRAFFIC ACCIDENT 307 0.0073
123 GAIT INABILITY 242 0.0072
124 BREAST CANCER STAGE II 60 0.0072
125 CHRONIC KIDNEY DISEASE 544 0.0072
126 JOINT INSTABILITY 10 0.0071
127 CATAPLEXY 10 0.0071
128 LOWER RESPIRATORY TRACT CONGESTION 12 0.0071
129 RED BLOOD CELL SEDIMENTATION RATE INCREASED 78 0.0070
130 CONTUSION 678 0.0070
131 DRUG DEPENDENCE 1132 0.0070
132 LIVE BIRTH 58 0.0069
133 SPINAL FUSION SURGERY 28 0.0069
134 SCLERITIS 11 0.0069
135 FOOD ALLERGY 53 0.0069
136 JOINT SWELLING 827 0.0068
137 MULTIPLE DRUG OVERDOSE INTENTIONAL 22 0.0068
138 IMPRISONMENT 12 0.0068
139 LOSS OF EMPLOYMENT 20 0.0066
140 SPONDYLITIS 24 0.0066
141 PSORIATIC ARTHROPATHY 264 0.0065
142 PREGNANCY 130 0.0065
143 NECK INJURY 19 0.0065
144 MYOSITIS 58 0.0065
145 HEPATIC CIRRHOSIS 121 0.0064
146 OSTEOARTHRITIS 273 0.0064
147 DEAFNESS NEUROSENSORY 21 0.0064
148 GENERAL SYMPTOM 47 0.0063
149 PRODUCT ADMINISTRATION INTERRUPTED 49 0.0062
150 SLEEP DISORDER 438 0.0062
151 INFUSION SITE BRUISING 13 0.0060
152 MUSCLE SPASTICITY 72 0.0059
153 BLOOD CHOLESTEROL INCREASED 271 0.0058
154 CERVICAL SPINAL STENOSIS 10 0.0058
155 DRUG INTOLERANCE 560 0.0058
156 FUNCTIONAL GASTROINTESTINAL DISORDER 20 0.0058
157 INFECTION 837 0.0058
158 RHEUMATOID ARTHRITIS 656 0.0058
159 PERIPHERAL SWELLING 863 0.0056
160 BACK DISORDER 91 0.0056
161 DELIRIUM 191 0.0055
162 ESSENTIAL HYPERTENSION 10 0.0055
163 PLEURITIC PAIN 15 0.0054
164 ANHEDONIA 142 0.0054
165 LIVER DISORDER 239 0.0054
166 INJURY 376 0.0053
167 CONGENITAL ANOMALY 41 0.0053
168 CRANIOCEREBRAL INJURY 16 0.0053
169 SPINA BIFIDA 11 0.0053
170 MATERNAL EXPOSURE DURING PREGNANCY 463 0.0052
171 INTERVERTEBRAL DISC DEGENERATION 48 0.0052
172 TOOTH LOSS 107 0.0052
173 NECK SURGERY 12 0.0052
174 EAR PAIN 100 0.0051
175 SPINAL OPERATION 63 0.0051
176 TENOSYNOVITIS 14 0.0051
177 CONFUSIONAL STATE 810 0.0050
178 HYPERHIDROSIS 644 0.0050
179 OEDEMA 269 0.0050
180 SLEEP APNOEA SYNDROME 94 0.0049
181 DEFORMITY 46 0.0049
182 BLOOD PRESSURE SYSTOLIC ABNORMAL 12 0.0049
183 OSTEOPOROSIS 197 0.0048
184 OSTEOPENIA 72 0.0047
185 LUNG DISORDER 231 0.0047
186 BACK INJURY 51 0.0047
187 INFUSION SITE REACTION 14 0.0047
188 WEIGHT FLUCTUATION 49 0.0047
189 SHOULDER OPERATION 20 0.0047
190 EAR INFECTION 124 0.0047
191 ABDOMINAL DISCOMFORT 779 0.0046
192 EYE INJURY 14 0.0046
193 COELIAC DISEASE 45 0.0046
194 NASOPHARYNGITIS 839 0.0045
195 RESPIRATORY DISORDER 134 0.0045
196 LUMBAR SPINAL STENOSIS 13 0.0044
197 DEVICE INFUSION ISSUE 11 0.0044
198 WHEEZING 263 0.0044
199 DENTAL CARIES 49 0.0044
200 IMPAIRED GASTRIC EMPTYING 60 0.0044
201 MUSCULOSKELETAL PAIN 230 0.0044
202 MUSCULOSKELETAL STIFFNESS 384 0.0044
203 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 207 0.0043
204 DEPRESSION 975 0.0043
205 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 72 0.0042
206 UPPER RESPIRATORY TRACT INFECTION 194 0.0042
207 HYPERSENSITIVITY 778 0.0042
208 BRAIN INJURY 42 0.0042
209 SENSITIVITY TO WEATHER CHANGE 22 0.0042
210 AMNESIA 272 0.0042
211 RADICULOPATHY 11 0.0042
212 ULCER HAEMORRHAGE 28 0.0041
213 INFUSION SITE HAEMORRHAGE 13 0.0039
214 MACULOPATHY 14 0.0039
215 CANCER PAIN 10 0.0039
216 PRESCRIBED UNDERDOSE 78 0.0039
217 THERAPY NON-RESPONDER 175 0.0039
218 FACIAL BONES FRACTURE 14 0.0039
219 SEASONAL ALLERGY 55 0.0039
220 JOINT STIFFNESS 101 0.0038
221 EPIGASTRIC DISCOMFORT 15 0.0038
222 IMMUNODEFICIENCY 57 0.0038
223 SUBSTANCE ABUSE 31 0.0038
224 ALOPECIA 731 0.0037
225 BONE DENSITY DECREASED 116 0.0037
226 ANXIETY 1053 0.0037
227 HIP SURGERY 20 0.0037
228 CREPITATIONS 11 0.0037
229 INFLAMMATION 190 0.0037
230 PRODUCT PRESCRIBING ISSUE 80 0.0037
231 MOBILITY DECREASED 263 0.0037
232 WEIGHT INCREASED 812 0.0036
233 SKIN ABRASION 17 0.0036
234 PSYCHOLOGICAL TRAUMA 31 0.0036
235 CARDIOMEGALY 44 0.0036
236 KNEE OPERATION 35 0.0036
237 INADEQUATE ANALGESIA 30 0.0035
238 HYPERAESTHESIA 29 0.0035
239 LEFT VENTRICULAR HYPERTROPHY 15 0.0035
240 INFUSION SITE SWELLING 22 0.0035
241 INFUSION SITE PRURITUS 11 0.0035
242 BODY TEMPERATURE INCREASED 71 0.0035
243 NON-CARDIAC CHEST PAIN 11 0.0035
244 ARTHRITIS INFECTIVE 16 0.0034
245 EXPOSURE TO TOXIC AGENT 11 0.0034
246 DIABETIC NEUROPATHY 17 0.0034
247 SPINAL OSTEOARTHRITIS 30 0.0034
248 INTENTIONAL PRODUCT USE ISSUE 297 0.0034
249 METABOLIC ENCEPHALOPATHY 10 0.0033
250 VASCULAR DEVICE INFECTION 15 0.0033
251 HYDROCEPHALUS 18 0.0033
252 DRY MOUTH 265 0.0033
253 RESPIRATORY DEPRESSION 40 0.0033
254 SPRUE-LIKE ENTEROPATHY 16 0.0032
255 TREATMENT FAILURE 268 0.0032
256 ASTHMA 364 0.0032
257 DIVERTICULUM INTESTINAL 14 0.0032
258 SOMNAMBULISM 21 0.0032
259 PARANASAL SINUS DISCOMFORT 12 0.0032
260 TENDERNESS 33 0.0032
261 RIB FRACTURE 65 0.0032
262 DERMATITIS CONTACT 36 0.0032
263 LEG AMPUTATION 13 0.0032
264 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 54 0.0031
265 SPINAL STENOSIS 13 0.0031
266 EMOTIONAL DISTRESS 380 0.0031
267 HANGOVER 11 0.0031
268 SURGERY 183 0.0031
269 RESPIRATORY ARREST 86 0.0031
270 CUSHINGOID 10 0.0031
271 PULMONARY TOXICITY 22 0.0031
272 ANKLE FRACTURE 48 0.0031
273 AUTISM SPECTRUM DISORDER 17 0.0031
274 GENERAL PHYSICAL HEALTH DETERIORATION 357 0.0031
275 FAILURE TO THRIVE 16 0.0031
276 ANTINUCLEAR ANTIBODY POSITIVE 10 0.0031
277 FREQUENT BOWEL MOVEMENTS 83 0.0031
278 ABDOMINAL HERNIA 14 0.0031
279 HAEMOGLOBIN INCREASED 14 0.0031
280 FOOT FRACTURE 58 0.0031
281 QUALITY OF LIFE DECREASED 41 0.0031
282 LUMBAR VERTEBRAL FRACTURE 14 0.0031
283 JOINT EFFUSION 21 0.0030
284 MALNUTRITION 34 0.0030
285 LIGAMENT SPRAIN 30 0.0030
286 SYNOVIAL CYST 14 0.0030
287 ATELECTASIS 29 0.0030
288 LYME DISEASE 10 0.0030
289 RENAL INJURY 89 0.0030
290 COMPRESSION FRACTURE 16 0.0030
291 FLUID RETENTION 151 0.0030
292 NERVE INJURY 33 0.0030
293 GINGIVAL SWELLING 13 0.0029
294 INSURANCE ISSUE 45 0.0029
295 PAIN 1803 0.0029
296 RHINITIS ALLERGIC 13 0.0029
297 MIGRAINE 276 0.0029
298 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 12 0.0029
299 C-REACTIVE PROTEIN INCREASED 105 0.0029
300 TOOTH INFECTION 38 0.0029
301 MAJOR DEPRESSION 21 0.0029
302 BLEPHAROSPASM 18 0.0029
303 MULTIPLE DRUG OVERDOSE 14 0.0028
304 MULTIPLE ALLERGIES 22 0.0028
305 RENAL FAILURE 372 0.0028
306 COMPLETED SUICIDE 233 0.0028
307 INFUSION SITE PAIN 36 0.0028
308 MENTAL DISORDER 121 0.0028
309 PATENT DUCTUS ARTERIOSUS 11 0.0028
310 TOOTH INJURY 12 0.0028
311 BIPOLAR DISORDER 30 0.0028
312 MEDICATION ERROR 153 0.0027
313 RENAL TUBULAR NECROSIS 27 0.0027
314 INTERVERTEBRAL DISC PROTRUSION 60 0.0027
315 TOOTH FRACTURE 30 0.0027
316 ALCOHOL USE 10 0.0027
317 LABORATORY TEST ABNORMAL 79 0.0027
318 ARTHRITIS 210 0.0027
319 ARTHRALGIA 1109 0.0027
320 FLANK PAIN 25 0.0027
321 DRUG SCREEN POSITIVE 21 0.0027
322 ACUTE RESPIRATORY FAILURE 51 0.0026
323 DRUG WITHDRAWAL SYNDROME 232 0.0026
324 DRUG TOXICITY 36 0.0026
325 MENISCUS INJURY 16 0.0026
326 DECREASED ACTIVITY 28 0.0026
327 MENTAL STATUS CHANGES 72 0.0026
328 NEURALGIA 63 0.0026
329 GALLBLADDER DISORDER 46 0.0026
330 PRODUCT FORMULATION ISSUE 17 0.0026
331 DYSPEPSIA 253 0.0026
332 SUSPECTED SUICIDE 12 0.0026
333 GASTROOESOPHAGEAL REFLUX DISEASE 206 0.0026
334 MULTIPLE FRACTURES 42 0.0026
335 CHEST PAIN 473 0.0026
336 ACUTE KIDNEY INJURY 388 0.0025
337 BONE LOSS 38 0.0025
338 HYPOAESTHESIA 378 0.0025
339 HYPERTENSION 534 0.0025
340 PYREXIA 872 0.0025
341 BENIGN PROSTATIC HYPERPLASIA 13 0.0025
342 TUBULOINTERSTITIAL NEPHRITIS 47 0.0025
343 ONYCHOMYCOSIS 11 0.0025
344 IMPAIRED QUALITY OF LIFE 36 0.0025
345 POST PROCEDURAL COMPLICATION 48 0.0025
346 DRUG USE DISORDER 21 0.0025
347 SKIN INFECTION 28 0.0025
348 INFUSION SITE ERYTHEMA 21 0.0025
349 RECTAL HAEMORRHAGE 107 0.0025
350 BLOOD TESTOSTERONE DECREASED 17 0.0025
351 TOOTH DISORDER 55 0.0025
352 TOOTH ABSCESS 25 0.0025
353 ARTERIOSCLEROSIS 23 0.0024
354 CEREBRAL DISORDER 18 0.0024
355 FOOD POISONING 13 0.0024
356 WHITE BLOOD CELL COUNT INCREASED 93 0.0024
357 ABDOMINAL TENDERNESS 12 0.0024
358 GINGIVITIS 13 0.0024
359 PANCREATITIS 127 0.0024
360 NAIL DISORDER 21 0.0024
361 PRODUCT USE IN UNAPPROVED INDICATION 594 0.0024
362 ULCER 38 0.0024
363 BLOOD PRESSURE DIASTOLIC INCREASED 11 0.0024
364 OSTEOMYELITIS 43 0.0024
365 OEDEMA PERIPHERAL 289 0.0024
366 PRURITUS 911 0.0024
367 PATHOLOGICAL FRACTURE 12 0.0024
368 UPPER LIMB FRACTURE 47 0.0024
369 UMBILICAL HERNIA 11 0.0024
370 FACIAL PAIN 21 0.0024
371 HYPERLIPIDAEMIA 28 0.0023
372 INTERVERTEBRAL DISC DISORDER 10 0.0023
373 POST PROCEDURAL INFECTION 19 0.0023
374 BRONCHITIS 172 0.0023
375 ABDOMINAL PAIN UPPER 478 0.0023
376 ENDOMETRIOSIS 11 0.0023
377 BRAIN FOG 36 0.0023
378 JOINT INJURY 49 0.0023
379 RENAL CYST 18 0.0023
380 SCOLIOSIS 14 0.0023
381 DRUG ABUSE 188 0.0023
382 ROTATOR CUFF SYNDROME 29 0.0023
383 WRIST FRACTURE 27 0.0023
384 DIVERTICULUM 16 0.0022
385 INFUSION SITE EXTRAVASATION 14 0.0022
386 NODULE 29 0.0022
387 DECREASED APPETITE 515 0.0022
388 URTICARIA 368 0.0022
389 SUICIDE ATTEMPT 133 0.0022
390 BACK PAIN 509 0.0022
391 LIVER FUNCTION TEST INCREASED 47 0.0022
392 EXPOSURE DURING PREGNANCY 135 0.0022
393 LARGE INTESTINE POLYP 15 0.0022
394 LOWER GASTROINTESTINAL HAEMORRHAGE 16 0.0022
395 GROIN PAIN 19 0.0022
396 HEPATITIS C 26 0.0022
397 PARANOIA 37 0.0021
398 RASH 934 0.0021
399 LIMB INJURY 58 0.0021
400 INSOMNIA 565 0.0021
401 PRODUCT SUBSTITUTION ISSUE 122 0.0021
402 SPUTUM DISCOLOURED 20 0.0021
403 FATIGUE 1637 0.0021
404 BLOOD PRESSURE SYSTOLIC INCREASED 41 0.0021
405 DYSPNOEA 1188 0.0021
406 GASTROINTESTINAL PAIN 23 0.0021
407 BONE DISORDER 38 0.0021
408 HIATUS HERNIA 27 0.0021
409 MUSCLE SPASMS 382 0.0021
410 SOCIAL AVOIDANT BEHAVIOUR 12 0.0021
411 WRONG PRODUCT ADMINISTERED 14 0.0021
412 TASTE DISORDER 42 0.0021
413 CONSTIPATION 451 0.0021
414 MEMORY IMPAIRMENT 284 0.0021
415 DIZZINESS POSTURAL 20 0.0021
416 COLITIS ULCERATIVE 92 0.0021
417 ORAL PAIN 46 0.0021
418 HAEMORRHOIDS 40 0.0020
419 FEELING OF BODY TEMPERATURE CHANGE 12 0.0020
420 KIDNEY INFECTION 40 0.0020
421 EYE INFECTION 23 0.0020
422 AFFECTIVE DISORDER 16 0.0020
423 INTENTIONAL DOSE OMISSION 58 0.0020
424 CARDIOMYOPATHY 30 0.0020
425 IMPAIRED DRIVING ABILITY 23 0.0020
426 HERNIA 39 0.0020
427 ANEURYSM 10 0.0020
428 INCOHERENT 13 0.0020
429 RESPIRATORY TRACT INFECTION 52 0.0020
430 DELUSION 31 0.0020
431 CORONARY ARTERY STENOSIS 10 0.0020
432 MENTAL IMPAIRMENT 48 0.0020
433 ILLNESS 204 0.0020
434 NECROSIS 11 0.0020
435 GAIT DISTURBANCE 377 0.0020
436 SINUS DISORDER 39 0.0020
437 HAEMATOCRIT DECREASED 39 0.0020
438 ARTERIOSCLEROSIS CORONARY ARTERY 13 0.0020
439 SEXUAL DYSFUNCTION 23 0.0020
440 MUSCULAR WEAKNESS 222 0.0020
441 DRUG ABUSER 12 0.0020
442 ENDOCARDITIS 10 0.0019
443 BLOOD URINE PRESENT 37 0.0019
444 VITAMIN D DEFICIENCY 19 0.0019
445 DEATH 1676 0.0019
446 GASTROENTERITIS VIRAL 35 0.0019
447 WEIGHT DECREASED 541 0.0019
448 SKIN LACERATION 21 0.0019
449 CHOLECYSTITIS 23 0.0019
450 PELVIC FRACTURE 15 0.0019
451 IMPAIRED WORK ABILITY 41 0.0019
452 LOCALISED INFECTION 46 0.0019
453 SPINAL FRACTURE 38 0.0019
454 CARDIAC DISORDER 177 0.0019
455 SUICIDAL IDEATION 173 0.0019
456 NAUSEA 1492 0.0019
457 PULMONARY MASS 28 0.0019
458 MUSCULOSKELETAL CHEST PAIN 29 0.0019
459 SMALL INTESTINAL OBSTRUCTION 23 0.0019
460 DECREASED INTEREST 11 0.0019
461 NECK PAIN 104 0.0019
462 CARPAL TUNNEL SYNDROME 26 0.0019
463 CYST 23 0.0019
464 PARAESTHESIA 291 0.0018
465 BEHAVIOUR DISORDER 10 0.0018
466 NERVE COMPRESSION 17 0.0018
467 CHOLECYSTECTOMY 21 0.0018
468 HAND FRACTURE 13 0.0018
469 CONDITION AGGRAVATED 557 0.0018
470 SINUS TACHYCARDIA 26 0.0018
471 PRODUCT USE ISSUE 344 0.0018
472 TOOTHACHE 33 0.0018
473 NEPHROPATHY 17 0.0018
474 UPPER-AIRWAY COUGH SYNDROME 15 0.0018
475 RED BLOOD CELL COUNT DECREASED 52 0.0018
476 ADVERSE EVENT 167 0.0018
477 PRODUCTIVE COUGH 86 0.0018
478 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 94 0.0018
479 MUSCULOSKELETAL DISCOMFORT 31 0.0018
480 PAIN IN JAW 51 0.0018
481 INTENTIONAL PRODUCT MISUSE 157 0.0018
482 ENCEPHALOPATHY 44 0.0018
483 GLOMERULAR FILTRATION RATE DECREASED 22 0.0018
484 BREAST MASS 12 0.0018
485 FEELING JITTERY 34 0.0018
486 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 11 0.0018
487 HEPATIC STEATOSIS 33 0.0018
488 FURUNCLE 14 0.0018
489 HYPOACUSIS 76 0.0018
490 PAIN IN EXTREMITY 519 0.0018
491 PNEUMONIA 570 0.0018
492 GINGIVAL PAIN 14 0.0018
493 CYSTITIS 56 0.0018
494 ACCIDENT 21 0.0018
495 PRODUCT DISPENSING ERROR 38 0.0017
496 UNRESPONSIVE TO STIMULI 45 0.0017
497 POOR VENOUS ACCESS 18 0.0017
498 HYSTERECTOMY 15 0.0017
499 NOCTURIA 21 0.0017
500 BLOOD POTASSIUM DECREASED 52 0.0017
501 MUSCLE DISORDER 14 0.0017
502 METABOLIC DISORDER 10 0.0017
503 DECUBITUS ULCER 14 0.0017
504 VOMITING 806 0.0017
505 BLADDER DISORDER 17 0.0017
506 BLOOD PRESSURE FLUCTUATION 41 0.0017
507 HEADACHE 1059 0.0017
508 RETCHING 36 0.0017
509 VISUAL IMPAIRMENT 209 0.0017
510 HIP FRACTURE 54 0.0017
511 ERECTILE DYSFUNCTION 43 0.0017
512 APNOEA 13 0.0017
513 SKIN ULCER 43 0.0017
514 BLOOD POTASSIUM INCREASED 27 0.0017
515 DIVERTICULITIS 46 0.0017
516 EUPHORIC MOOD 17 0.0017
517 TEMPERATURE INTOLERANCE 17 0.0016
518 FEELING HOT 101 0.0016
519 CHOLECYSTITIS CHRONIC 11 0.0016
520 HEAD INJURY 52 0.0016
521 ASTHENIA 616 0.0016
522 TRICUSPID VALVE INCOMPETENCE 13 0.0016
523 DRUG DISPENSING ERROR 25 0.0016
524 INCREASED TENDENCY TO BRUISE 15 0.0016
525 POSTOPERATIVE WOUND INFECTION 11 0.0016
526 SPINAL PAIN 19 0.0016
527 FALL 539 0.0016
528 THERAPY CESSATION 83 0.0016
529 THINKING ABNORMAL 30 0.0016
530 BLOOD CALCIUM DECREASED 18 0.0016
531 ANKYLOSING SPONDYLITIS 21 0.0016
532 BLOOD SODIUM DECREASED 30 0.0016
533 LYMPHOEDEMA 11 0.0016
534 MICTURITION URGENCY 18 0.0016
535 ABSCESS 25 0.0016
536 CONJUNCTIVITIS 29 0.0016
537 THERAPEUTIC RESPONSE UNEXPECTED 70 0.0016
538 BLOOD PRESSURE ABNORMAL 31 0.0016
539 ADVERSE DRUG REACTION 140 0.0016
540 ATRIAL SEPTAL DEFECT 13 0.0016
541 CORONARY ARTERY DISEASE 47 0.0016
542 CONCUSSION 12 0.0015
543 DRUG EFFECT DECREASED 83 0.0015
544 FRACTURE 29 0.0015
545 SKIN LESION 42 0.0015
546 ELECTROCARDIOGRAM ABNORMAL 12 0.0015
547 CHOLELITHIASIS 50 0.0015
548 BODY TEMPERATURE DECREASED 15 0.0015
549 DYSPNOEA EXERTIONAL 57 0.0015
550 URINARY TRACT INFECTION 258 0.0015
551 CARDIAC OPERATION 13 0.0015
552 ORAL DISCOMFORT 21 0.0015
553 RENAL PAIN 16 0.0015
554 APPETITE DISORDER 10 0.0015
555 RASH ERYTHEMATOUS 72 0.0015
556 GOUT 27 0.0015
557 ACCIDENTAL OVERDOSE 55 0.0015
558 MASS 21 0.0015
559 CARDIAC MURMUR 13 0.0015
560 RENAL DISORDER 70 0.0015
561 MITRAL VALVE INCOMPETENCE 17 0.0015
562 THERAPY INTERRUPTED 107 0.0015
563 OBSESSIVE-COMPULSIVE DISORDER 12 0.0015
564 DRUG INEFFECTIVE 1963 0.0015
565 EMPHYSEMA 15 0.0015
566 DYSPHAGIA 141 0.0015
567 COLITIS ISCHAEMIC 10 0.0015
568 UNEVALUABLE EVENT 111 0.0015
569 DRUG-INDUCED LIVER INJURY 46 0.0015
570 RESPIRATORY RATE INCREASED 13 0.0015
571 EAR DISCOMFORT 15 0.0015
572 HYPERCALCAEMIA 18 0.0015
573 PERIPHERAL COLDNESS 20 0.0015
574 URINARY INCONTINENCE 43 0.0014
575 ILEUS 18 0.0014
576 DISTURBANCE IN ATTENTION 78 0.0014
577 MOOD SWINGS 46 0.0014
578 NEUROPATHY PERIPHERAL 137 0.0014
579 CARDIO-RESPIRATORY ARREST 60 0.0014
580 ABDOMINAL PAIN 333 0.0014
581 DIARRHOEA 923 0.0014
582 EMOTIONAL DISORDER 44 0.0014
583 CANDIDA INFECTION 24 0.0014
584 BLOOD PRESSURE INCREASED 217 0.0014
585 PRODUCT DOSE OMISSION IN ERROR 40 0.0014
586 CELLULITIS 71 0.0014
587 SINUS CONGESTION 19 0.0014
588 INTESTINAL OBSTRUCTION 53 0.0014
589 HOSPITALISATION 216 0.0014
590 VITAMIN D DECREASED 12 0.0014
591 PRODUCT DISTRIBUTION ISSUE 13 0.0014
592 PRODUCT PHYSICAL ISSUE 28 0.0014
593 DISORIENTATION 55 0.0014
594 NASAL DISCOMFORT 11 0.0014
595 BLOOD ALBUMIN DECREASED 11 0.0014
596 RESPIRATORY TRACT CONGESTION 22 0.0014
597 BONE PAIN 81 0.0014
598 CARDIAC ARREST 114 0.0014
599 FEEDING DISORDER 28 0.0014
600 FUNGAL INFECTION 46 0.0014
601 MALAISE 604 0.0014
602 RESTLESS LEGS SYNDROME 25 0.0014
603 SPINAL DISORDER 13 0.0014
604 PHARYNGITIS 17 0.0014
605 BEDRIDDEN 18 0.0014
606 GASTRIC ULCER 26 0.0014
607 UPPER GASTROINTESTINAL HAEMORRHAGE 23 0.0014
608 TOOTH EXTRACTION 17 0.0014
609 PULMONARY CONGESTION 18 0.0014
610 PULMONARY OEDEMA 61 0.0014
611 HERPES ZOSTER 78 0.0014
612 CARDIAC FAILURE CONGESTIVE 109 0.0014
613 TENDONITIS 21 0.0014
614 SOMNOLENCE 273 0.0014
615 HEAD DISCOMFORT 24 0.0014
616 COVID-19 PNEUMONIA 16 0.0014
617 BLOOD PRESSURE DIASTOLIC DECREASED 10 0.0014
618 HYPOPHOSPHATAEMIA 10 0.0014
619 BLOOD IRON DECREASED 16 0.0013
620 NASAL CONGESTION 79 0.0013
621 POLLAKIURIA 56 0.0013
622 HAIR DISORDER 11 0.0013
623 HYPOXIA 47 0.0013
624 CLOSTRIDIUM DIFFICILE INFECTION 29 0.0013
625 HEART RATE IRREGULAR 30 0.0013
626 HYPERSOMNIA 38 0.0013
627 ADRENAL INSUFFICIENCY 16 0.0013
628 HOSPICE CARE 13 0.0013
629 DIZZINESS 656 0.0013
630 ACIDOSIS 10 0.0013
631 DYSURIA 48 0.0013
632 DYSARTHRIA 49 0.0013
633 HOT FLUSH 98 0.0013
634 PHARYNGITIS STREPTOCOCCAL 14 0.0013
635 THROMBOSIS 104 0.0013
636 ELECTROLYTE IMBALANCE 15 0.0013
637 ORAL CANDIDIASIS 17 0.0013
638 SPLENOMEGALY 15 0.0013
639 METASTASES TO BONE 21 0.0013
640 MUSCLE STRAIN 11 0.0013
641 PHARMACEUTICAL PRODUCT COMPLAINT 33 0.0013
642 NEOPLASM PROGRESSION 44 0.0013
643 PSORIASIS 165 0.0013
644 OFF LABEL USE 1104 0.0013
645 FEMUR FRACTURE 39 0.0013
646 HEART RATE DECREASED 44 0.0013
647 HYPOPHAGIA 32 0.0013
648 DEPRESSED MOOD 66 0.0012
649 SNEEZING 28 0.0012
650 AFFECT LABILITY 12 0.0012
651 INFLUENZA 139 0.0012
652 SENSORY DISTURBANCE 20 0.0012
653 LUNG INFILTRATION 11 0.0012
654 SINUS BRADYCARDIA 12 0.0012
655 LOSS OF CONSCIOUSNESS 159 0.0012
656 MUSCLE TIGHTNESS 20 0.0012
657 GASTROINTESTINAL INFECTION 11 0.0012
658 HYPERKALAEMIA 43 0.0012
659 PROCEDURAL PAIN 34 0.0012
660 INTERNAL HAEMORRHAGE 14 0.0012
661 PHOTOPHOBIA 23 0.0012
662 HEPATOMEGALY 12 0.0012
663 OROPHARYNGEAL PAIN 113 0.0012
664 OROPHARYNGEAL DISCOMFORT 11 0.0012
665 HYPOTENSION 244 0.0012
666 THROMBOCYTOPENIA 136 0.0012
667 LEUKOCYTOSIS 22 0.0012
668 ANGER 41 0.0012
669 HAIR COLOUR CHANGES 15 0.0012
670 RENAL IMPAIRMENT 101 0.0012
671 DEEP VEIN THROMBOSIS 78 0.0012
672 PULMONARY HYPERTENSION 25 0.0012
673 TOXICITY TO VARIOUS AGENTS 202 0.0012
674 IRON DEFICIENCY ANAEMIA 11 0.0012
675 FULL BLOOD COUNT DECREASED 24 0.0012
676 PARALYSIS 17 0.0012
677 MUSCLE ATROPHY 15 0.0012
678 HAEMATEMESIS 30 0.0012
679 EATING DISORDER 25 0.0012
680 DEVICE RELATED INFECTION 18 0.0012
681 URINARY RETENTION 39 0.0012
682 DEHYDRATION 155 0.0012
683 BLOOD MAGNESIUM DECREASED 10 0.0012
684 OSTEONECROSIS 38 0.0012
685 PANCREATITIS ACUTE 26 0.0012
686 OXYGEN SATURATION DECREASED 65 0.0012
687 ORTHOSTATIC HYPOTENSION 20 0.0011
688 INTENTIONAL DRUG MISUSE 24 0.0011
689 WHITE BLOOD CELL COUNT DECREASED 124 0.0011
690 DIABETES MELLITUS 87 0.0011
691 MOUTH ULCERATION 24 0.0011
692 IMMUNE SYSTEM DISORDER 15 0.0011
693 COLD SWEAT 20 0.0011
694 HALLUCINATION, AUDITORY 18 0.0011
695 TINNITUS 52 0.0011
696 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
697 BACTERIAL INFECTION 21 0.0011
698 PERICARDIAL EFFUSION 26 0.0011
699 BODY HEIGHT DECREASED 12 0.0011
700 HAIR TEXTURE ABNORMAL 15 0.0011
701 MADAROSIS 13 0.0011
702 THIRST 20 0.0011
703 PRODUCT DOSE OMISSION ISSUE 327 0.0011
704 HAEMOGLOBIN DECREASED 114 0.0011
705 HYPOKALAEMIA 51 0.0011
706 PULMONARY ARTERIAL HYPERTENSION 16 0.0011
707 SEPSIS 123 0.0011
708 PULMONARY THROMBOSIS 12 0.0011
709 TREMOR 182 0.0011
710 GASTROENTERITIS 16 0.0011
711 EPISTAXIS 82 0.0011
712 DYSSTASIA 32 0.0011
713 EYE DISORDER 36 0.0011
714 CATARACT 65 0.0011
715 HEART RATE INCREASED 108 0.0011
716 HYPOTHERMIA 11 0.0011
717 BLOOD PRESSURE DECREASED 72 0.0011
718 RHINORRHOEA 70 0.0011
719 COAGULOPATHY 18 0.0011
720 ANAEMIA 206 0.0011
721 HUNGER 15 0.0011
722 LYMPHOCYTE COUNT DECREASED 19 0.0011
723 PRODUCT DOSE OMISSION 70 0.0011
724 COGNITIVE DISORDER 50 0.0011
725 TACHYCARDIA 95 0.0011
726 ABDOMINAL PAIN LOWER 27 0.0011
727 NO THERAPEUTIC RESPONSE 13 0.0011
728 STAPHYLOCOCCAL INFECTION 35 0.0011
729 ACTIVITIES OF DAILY LIVING IMPAIRED 21 0.0011
730 LETHARGY 61 0.0011
731 MULTIPLE ORGAN DYSFUNCTION SYNDROME 30 0.0011
732 AGGRESSION 53 0.0011
733 BLOOD CREATININE INCREASED 69 0.0011
734 BLOOD COUNT ABNORMAL 16 0.0011
735 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 75 0.0011
736 SCAR 18 0.0011
737 HAEMATURIA 36 0.0011
738 MUSCULOSKELETAL DISORDER 20 0.0010
739 PANIC ATTACK 38 0.0010
740 TREATMENT NONCOMPLIANCE 57 0.0010
741 INCONTINENCE 11 0.0010
742 NERVOUSNESS 54 0.0010
743 COMA 49 0.0010
744 GASTRITIS 27 0.0010
745 PLASMA CELL MYELOMA 40 0.0010
746 ACUTE HEPATIC FAILURE 14 0.0010
747 DECREASED IMMUNE RESPONSIVENESS 10 0.0010
748 INTERNATIONAL NORMALISED RATIO INCREASED 29 0.0010
749 PROSTATIC SPECIFIC ANTIGEN INCREASED 14 0.0010
750 BLOOD UREA INCREASED 17 0.0010
751 SEIZURE 117 0.0010
752 DRUG EFFECT LESS THAN EXPECTED 15 0.0010
753 HALLUCINATION 76 0.0010
754 COLON CANCER 15 0.0010
755 FEELING ABNORMAL 241 0.0010
756 ASPIRATION 11 0.0010
757 ABDOMINAL DISTENSION 104 0.0010
758 LACRIMATION INCREASED 30 0.0010
759 VENTRICULAR FIBRILLATION 11 0.0010
760 ATRIAL FIBRILLATION 96 0.0010
761 CHILLS 115 0.0010
762 OCULAR DISCOMFORT 11 0.0010
763 PHARYNGEAL OEDEMA 15 0.0010
764 ORAL HERPES 19 0.0010
765 THERAPEUTIC RESPONSE DECREASED 59 0.0010
766 GASTROINTESTINAL HAEMORRHAGE 81 0.0010
767 FAECES DISCOLOURED 21 0.0010
768 MYOCARDIAL ISCHAEMIA 11 0.0010
769 PRODUCT AVAILABILITY ISSUE 22 0.0010
770 MYALGIA 164 0.0010
771 HYPOKINESIA 14 0.0010
772 MYOCARDIAL INFARCTION 168 0.0010
773 PNEUMONIA ASPIRATION 24 0.0010
774 BALANCE DISORDER 83 0.0010
775 DIABETES MELLITUS INADEQUATE CONTROL 17 0.0010
776 PLATELET COUNT DECREASED 102 0.0010
777 ACUTE MYOCARDIAL INFARCTION 28 0.0009
778 COUGH 266 0.0009
779 RESPIRATORY FAILURE 69 0.0009
780 POST PROCEDURAL HAEMORRHAGE 11 0.0009
781 DRY EYE 47 0.0009
782 EYE PAIN 53 0.0009
783 THROAT IRRITATION 42 0.0009
784 SKIN DISCOLOURATION 43 0.0009
785 VERTIGO 57 0.0009
786 FLATULENCE 53 0.0009
787 HYPOMAGNESAEMIA 13 0.0009
788 HEREDITARY ANGIOEDEMA 10 0.0009
789 OSTEONECROSIS OF JAW 23 0.0009
790 POOR QUALITY SLEEP 20 0.0009
791 COLITIS 35 0.0009
792 SKIN FISSURES 18 0.0009
793 PSYCHOTIC DISORDER 27 0.0009
794 AGITATION 67 0.0009
795 MUSCLE TWITCHING 21 0.0009
796 ABNORMAL BEHAVIOUR 36 0.0009
797 VENTRICULAR TACHYCARDIA 15 0.0009
798 ANGINA PECTORIS 26 0.0009
799 LYMPHOMA 14 0.0009
800 ADVERSE REACTION 12 0.0009
801 LYMPHADENOPATHY 32 0.0009
802 RESTLESSNESS 33 0.0009
803 VIRAL INFECTION 30 0.0009
804 IRRITABILITY 54 0.0009
805 BASAL CELL CARCINOMA 14 0.0009
806 HAEMOPTYSIS 25 0.0009
807 MALIGNANT MELANOMA 12 0.0009
808 DEMENTIA 25 0.0009
809 TENDON RUPTURE 11 0.0009
810 FISTULA 10 0.0009
811 GENERALISED OEDEMA 11 0.0009
812 PRODUCT TASTE ABNORMAL 12 0.0009
813 SEROTONIN SYNDROME 17 0.0009
814 SPEECH DISORDER 46 0.0009
815 HYPOTHYROIDISM 28 0.0009
816 GASTRIC DISORDER 30 0.0009
817 LIMB DISCOMFORT 27 0.0009
818 RENAL FAILURE ACUTE 37 0.0009
819 CHOKING 17 0.0009
820 SYNCOPE 87 0.0009
821 PULMONARY EMBOLISM 82 0.0009
822 HYPOAESTHESIA ORAL 13 0.0009
823 FEELING COLD 24 0.0009
824 EYE SWELLING 32 0.0009
825 INTENTIONAL OVERDOSE 55 0.0009
826 PLEURAL EFFUSION 52 0.0009
827 RASH MACULO-PAPULAR 19 0.0009
828 ANOREXIA 11 0.0009
829 SEPTIC SHOCK 37 0.0008
830 MULTIPLE SCLEROSIS RELAPSE 58 0.0008
831 PALLOR 23 0.0008
832 THYROID DISORDER 13 0.0008
833 AGEUSIA 21 0.0008
834 CHROMATURIA 19 0.0008
835 DEAFNESS 22 0.0008
836 MOVEMENT DISORDER 27 0.0008
837 SWELLING FACE 54 0.0008
838 CYANOSIS 13 0.0008
839 NEOPLASM MALIGNANT 55 0.0008
840 DRUG INTERACTION 130 0.0008
841 HAEMATOCHEZIA 45 0.0008
842 RASH PRURITIC 44 0.0008
843 DEPRESSED LEVEL OF CONSCIOUSNESS 32 0.0008
844 MOOD ALTERED 22 0.0008
845 NERVOUS SYSTEM DISORDER 25 0.0008
846 CRYING 29 0.0008
847 HYPERGLYCAEMIA 29 0.0008
848 COVID-19 139 0.0008
849 INFLUENZA LIKE ILLNESS 65 0.0008
850 PRURITUS GENERALISED 17 0.0008
851 DISSEMINATED INTRAVASCULAR COAGULATION 11 0.0008
852 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 140 0.0008
853 MULTIPLE SCLEROSIS 37 0.0008
854 PALPITATIONS 90 0.0008
855 BLOOD ALKALINE PHOSPHATASE INCREASED 19 0.0008
856 HEPATOTOXICITY 17 0.0008
857 APHASIA 23 0.0008
858 LEUKOPENIA 38 0.0008
859 PRODUCT PRESCRIBING ERROR 18 0.0008
860 CEREBROVASCULAR ACCIDENT 128 0.0008
861 MIDDLE INSOMNIA 14 0.0007
862 SKIN DISORDER 25 0.0007
863 VISION BLURRED 102 0.0007
864 SKIN HAEMORRHAGE 11 0.0007
865 BURNING SENSATION 52 0.0007
866 TRANSIENT ISCHAEMIC ATTACK 25 0.0007
867 METASTASES TO LIVER 13 0.0007
868 SWOLLEN TONGUE 23 0.0007
869 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
870 HEPATIC FAILURE 22 0.0007
871 ERYTHEMA 150 0.0007
872 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 17 0.0007
873 CORONARY ARTERY OCCLUSION 10 0.0007
874 EPILEPSY 22 0.0007
875 APHONIA 10 0.0007
876 MALIGNANT NEOPLASM PROGRESSION 73 0.0007
877 BLOOD TEST ABNORMAL 10 0.0007
878 CARDIOVASCULAR DISORDER 18 0.0007
879 PRESYNCOPE 17 0.0007
880 PREMATURE BABY 21 0.0007
881 OCULAR HYPERAEMIA 33 0.0007
882 HAEMATOMA 18 0.0007
883 PNEUMOTHORAX 11 0.0007
884 COMPLICATION ASSOCIATED WITH DEVICE 10 0.0007
885 ABASIA 17 0.0007
886 FLUID OVERLOAD 10 0.0007
887 HYPOCALCAEMIA 13 0.0007
888 CARDIAC FAILURE 55 0.0007
889 ALANINE AMINOTRANSFERASE INCREASED 42 0.0007
890 CHEST DISCOMFORT 70 0.0007
891 MELAENA 15 0.0007
892 INCREASED APPETITE 13 0.0007
893 HAEMORRHAGE 71 0.0007
894 TRANSAMINASES INCREASED 15 0.0007
895 ELECTROCARDIOGRAM QT PROLONGED 24 0.0007
896 DYSPHONIA 39 0.0007
897 HEPATITIS 17 0.0007
898 INJECTION SITE BRUISING 53 0.0007
899 HALLUCINATION, VISUAL 14 0.0007
900 EYE IRRITATION 38 0.0007
901 ASPARTATE AMINOTRANSFERASE INCREASED 35 0.0007
902 UNDERDOSE 48 0.0007
903 DIPLOPIA 17 0.0007
904 SKIN CANCER 14 0.0006
905 EJECTION FRACTION DECREASED 10 0.0006
906 BRADYCARDIA 34 0.0006
907 LOCAL SWELLING 11 0.0006
908 METABOLIC ACIDOSIS 20 0.0006
909 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 34 0.0006
910 RESPIRATORY DISTRESS 17 0.0006
911 DRY SKIN 82 0.0006
912 DYSGEUSIA 45 0.0006
913 VISUAL ACUITY REDUCED 20 0.0006
914 PRODUCT QUALITY ISSUE 81 0.0006
915 NEUTROPHIL COUNT DECREASED 24 0.0006
916 ASCITES 17 0.0006
917 DERMATITIS 12 0.0006
918 ERUCTATION 11 0.0006
919 HYPONATRAEMIA 32 0.0006
920 BLINDNESS 23 0.0006
921 HYPOGLYCAEMIA 27 0.0006
922 DRUG DOSE OMISSION 92 0.0006
923 LACTIC ACIDOSIS 18 0.0006
924 BLOOD CREATINE PHOSPHOKINASE INCREASED 16 0.0006
925 DRUG ADMINISTRATION ERROR 17 0.0006
926 FLUSHING 56 0.0006
927 DRUG EFFECT INCOMPLETE 20 0.0006
928 DYSKINESIA 22 0.0005
929 DISEASE PROGRESSION 64 0.0005
930 BLOOD GLUCOSE INCREASED 100 0.0005
931 INJECTION SITE URTICARIA 13 0.0005
932 SHOCK 12 0.0005
933 SKIN EXFOLIATION 44 0.0005
934 INJECTION SITE RASH 16 0.0005
935 RASH MACULAR 18 0.0005
936 FEBRILE NEUTROPENIA 34 0.0005
937 LUNG NEOPLASM MALIGNANT 21 0.0005
938 ABNORMAL DREAMS 14 0.0005
939 RHABDOMYOLYSIS 21 0.0005
940 BLOOD GLUCOSE DECREASED 24 0.0005
941 INTENTIONAL SELF-INJURY 10 0.0005
942 PANCREATIC CARCINOMA 14 0.0005
943 FEAR 13 0.0005
944 JAUNDICE 13 0.0005
945 EXPIRED PRODUCT ADMINISTERED 16 0.0005
946 THROAT TIGHTNESS 13 0.0005
947 EYE PRURITUS 16 0.0005
948 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 95 0.0005
949 DEVICE DISLOCATION 20 0.0005
950 INJECTION SITE SWELLING 35 0.0005
951 HEPATIC FUNCTION ABNORMAL 17 0.0005
952 THERAPEUTIC RESPONSE SHORTENED 15 0.0005
953 LIP SWELLING 15 0.0004
954 PANCYTOPENIA 25 0.0004
955 PNEUMONITIS 12 0.0004
956 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
957 EXPOSURE VIA SKIN CONTACT 11 0.0004
958 ARRHYTHMIA 20 0.0004
959 CEREBRAL HAEMORRHAGE 15 0.0004
960 INTERSTITIAL LUNG DISEASE 20 0.0004
961 NEUTROPENIA 56 0.0004
962 ACNE 31 0.0004
963 PAIN OF SKIN 11 0.0004
964 CONVULSION 23 0.0004
965 INJECTION SITE MASS 14 0.0004
966 INCORRECT DOSE ADMINISTERED 86 0.0004
967 EXTRA DOSE ADMINISTERED 15 0.0004
968 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 26 0.0004
969 SKIN IRRITATION 16 0.0003
970 VAGINAL HAEMORRHAGE 15 0.0003
971 LIVER FUNCTION TEST ABNORMAL 10 0.0003
972 PRODUCT ADHESION ISSUE 12 0.0003
973 INJECTION SITE REACTION 23 0.0003
974 WRONG TECHNIQUE IN DRUG USAGE PROCESS 12 0.0003
975 INJECTION SITE PAIN 101 0.0003
976 INJECTION SITE PRURITUS 22 0.0003
977 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
978 ANGIOEDEMA 14 0.0003
979 DEVICE ISSUE 28 0.0003
980 ECZEMA 16 0.0003
981 DERMATITIS ATOPIC 16 0.0003
982 INJECTION SITE ERYTHEMA 36 0.0003
983 DEVICE LEAKAGE 12 0.0003
984 ANAPHYLACTIC REACTION 15 0.0003
985 INJECTION SITE HAEMORRHAGE 19 0.0002
986 NO ADVERSE EVENT 42 0.0002
987 DISEASE RECURRENCE 11 0.0002
988 RENAL CANCER 11 0.0002
989 PROSTATE CANCER 17 0.0002
990 ACCIDENTAL EXPOSURE TO PRODUCT 21 0.0002
991 DEVICE MALFUNCTION 14 0.0002
992 BREAST CANCER 18 0.0002
993 BLADDER CANCER 11 0.0002